LifeTech Scientific invests in Affector Medtech

LifeTech Scientific Corporation announced a strategic investment in Affector Medtech (Suzhou) Ltd, a high-tech company specializing in electrophysiology and innovative medical devices. Through its subsidiary, Lifetech Scientific (Shenzhen) Co., Ltd., LifeTech Scientific will invest a total of CNY150 million in cash, acquiring a 30% equity interest in Affector Medtech upon completion of all investment stages, with 22.22% acquired immediately after the initial phase. The investment is staged and contingent on milestones, including employment and confidentiality agreements. The collaboration includes a strategic agreement to jointly promote cardiac intervention imaging platform products, with LifeTech securing exclusive priority cooperation and overseas distribution rights for Affector Medtech's electrophysiology-related products, including the StarTrek 3D Mapping System. The investment will be funded through LifeTech's internal resources.